Association between calcium channel blockers and gingival hyperplasia

Journal of Clinical Periodontology

Volumn 37, Issue 7, 2010, Pages 625-630

  Kaur, Gaganpreet ^a   Verhamme, Katia M C ^a   Dieleman, Jeanne P ^a   Vanrolleghem, Ann ^a   Van Soest, Eva M ^a   Stricker, Bruno H Ch ^a   Sturkenboom, Miriam C J M ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

Calcium channel blockers; Gingival hyperplasia

Indexed keywords

ANGIOTENSIN 1 RECEPTOR ANTAGONIST; CALCIUM CHANNEL BLOCKING AGENT; DIHYDROPYRIDINE DERIVATIVE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; THIAZEPINE DERIVATIVE;

ARTICLE; CASE CONTROL STUDY; CHEMICALLY INDUCED DISORDER; DOSE RESPONSE; EPIDEMIOLOGY; FEMALE; GINGIVA HYPERPLASIA; HUMAN; MALE; MIDDLE AGED; STATISTICAL MODEL; CHEMICALLY INDUCED;

ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; CALCIUM CHANNEL BLOCKERS; CASE-CONTROL STUDIES; CONFOUNDING FACTORS (EPIDEMIOLOGY); DIHYDROPYRIDINES; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; GINGIVAL HYPERPLASIA; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; THIAZEPINES;

EID: 77953563372     PISSN: 03036979     EISSN: 1600051X     Source Type: Journal    
DOI: 10.1111/j.1600-051X.2010.01574.x     Document Type: Article

References (31)

1. Akimoto, Y., Tanaka, S., Omata, H., Shibutani, J., Nakano, Y., Kaneko, K., Kawana, T., Teshigawara, H., Nakao, S. Fujii, A. (1991) Gingival hyperplasia induced by nifedipine. Journal of Nihon University School of Dentistry 33, 174 181.
2. Barak, S., Engelberg, I. S. Hiss, J. (1987) Gingival hyperplasia caused by nifedipine. Histopathologic findings. Journal of Periodontology 58, 639 642.
3. Beck, J. D. Offenbacher, S. (2005) Systemic effects of periodontitis: epidemiology of periodontal disease and cardiovascular disease. Journal of Periodontology 76, 2089 2100.
4. Bhatia, V., Mittal, A., Parida, A. K., Talwar, R. Kaul, U. (2007) Amlodipine induced gingival hyperplasia: a rare entity. International Journal of Cardiology 122, e23 e24.
5. Bowman, J. M., Levy, B. A. Grubb, R. V. (1988) Gingival overgrowth induced by diltiazem. A case report. Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontics 65, 183 185.
6. Burkes, E. J. Jr., Jacoway, J. R., Stevens, D. T. Braddock, M. E. (1992) Nifedipine-induced gingival hyperplasia. The Journal of the Tennessee Dental Association 72, 35 37.
7. Calsina, G., Ramon, J. M. Echeverria, J. J. (2002) Effects of smoking on periodontal tissues. Journal of Clinical Periodontology 29, 771 776.
8. Ellis, J. S., Seymour, R. A., Steele, J. G., Robertson, P., Butler, T. J. Thomason, J. M. (1999) Prevalence of gingival overgrowth induced by calcium channel blockers: a community-based study. Journal of Periodontology 70, 63 67.
9. Fattore, L., Stablein, M., Bredfeldt, G., Semla, T., Moran, M. Doherty-Greenberg, J. M. (1991) Gingival hyperplasia: a side effect of nifedipine and diltiazem. Special Care in Dentistry 11, 107 109.
10. Greenland, S. (1989) Modeling and variable selection in epidemiologic analysis. American Journal of Public Health 79, 340 349.
11. Harel-Raviv, M., Eckler, M., Lalani, K., Raviv, E. Gornitsky, M. (1995) Nifedipine-induced gingival hyperplasia. A comprehensive review and analysis. Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontics 79, 715 722.
12. James, J. A. Linden, G. J. (1992) Nifedipine-induced gingival hyperplasia. Dental Update 19, 440 441.
13. Kimmel, S. E. Storm, B. L. (eds) 2006) Textbook of Pharmacoepidemiology.
14. Lamberts, H., Wood, M. Hofmans-Okkes, I. M. (1992) International primary care classifications: the effect of fifteen years of evolution. Family Practice 9, 330 339.
15. McGaw, T., Lam, S. Coates, J. (1987) Cyclosporin-induced gingival overgrowth: correlation with dental plaque scores, gingivitis scores, and cyclosporin levels in serum and saliva. Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontics 64, 293 297.
16. Meisel, P., Schwahn, C., John, U., Kroemer, H. K. Kocher, T. (2005) Calcium antagonists and deep gingival pockets in the population-based SHIP study. British Journal of Clinical Pharmacology 60, 552 559.
17. Miller, C. S. Damm, D. D. (1992) Incidence of verapamil-induced gingival hyperplasia in a dental population. Journal of Periodontology 63, 453 456.
18. Miranda, J., Brunet, L., Roset, P., Berini, L., Farre, M. Mendieta, C. (2001) Prevalence and risk of gingival enlargement in patients treated with nifedipine. Journal of Periodontology 72, 605 611. (Pubitemid 32479933)
19. Nishikawa, S., Nagata, T., Morisaki, I., Oka, T. Ishida, H. (1996) Pathogenesis of drug-induced gingival overgrowth. A review of studies in the rat model. Journal of Periodontology 67, 463 471.
20. Perlik, F., Kolinova, M., Zvarova, J. Patzelova, V. (1995) Phenytoin as a risk factor in gingival hyperplasia. Therapeutic Drug Monitoring 17, 445 448.
21. Schrijvers, A. (1997) Health and Health Care in the Netherlands. A Critical Self-Assessment of Dutch Experts in Medical and Health Sciences.
22. Seymour, R. A. (1991) Calcium channel blockers and gingival overgrowth. British Dental Journal 170, 376 379.
23. Seymour, R. A., Ellis, J. S., Thomason, J. M., Monkman, S. Idle, J. R. (1994) Amlodipine-induced gingival overgrowth. Journal of Clinical Periodontology 21, 281 283.
24. Tagawa, T., Nakamura, H. Murata, M. (1990) Marked gingival hyperplasia induced by nifedipine. International Journal of Oral and Maxillofacial Surgery 19, 72 73.
25. Tam, I. M. Wandres, D. L. (1992) Calcium-channel blockers and gingival hyperplasia. The Annals of Pharmacotherapy 26, 213 214.
26. Tavassoli, S., Yamalik, N., Caglayan, F., Caglayan, G. Eratalay, K. (1998) The clinical effects of nifedipine on periodontal status. Journal of Periodontology 69, 108 112.
27. Torpet, L. A., Kragelund, C., Reibel, J. Nauntofte, B. (2004) Oral adverse drug reactions to cardiovascular drugs. Critical Reviews in Oral Biology and Medicine 15, 28 46.
28. van der Lei, J., Duisterhout, J. S., Westerhof, H. P., van der Does, E., Cromme, P. V., Boon, W. M. van Bemmel, J. H. (1993) The introduction of computer-based patient records in The Netherlands. Annals of Internal Medicine 119, 1036 1041.
29. Vlug, A. E., van der Lei, J., Mosseveld, B. M., van Wijk, M. A., van der Linden, P. D., Sturkenboom, M. C. van Bemmel, J. H. (1999) Postmarketing surveillance based on electronic patient records: the IPCI project. Methods of Information in Medicine 38, 339 344.
30. WHO. (2010) Guidelines for ATC classification and DDD assignment 2010, Oslo
31. Yamasaki, A., Rose, G. G., Pinero, G. J. Mahan, C. J. (1987) Ultrastructure of fibroblasts in cyclosporin A-induced gingival hyperplasia. Journal of Oral Pathology 16, 129 134.